XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.8698
+0.0198 (2.33%)
Jan 28, 2026, 11:48 AM EST - Market open
XTL Biopharmaceuticals Employees
XTL Biopharmaceuticals had 10 employees as of December 31, 2024. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
$96,800
Profits / Employee
-$630,800
Market Cap
8.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2016 | 7 | 1 | 16.67% | 2 | 5 |
| Dec 31, 2015 | 6 | 1 | 20.00% | 3 | 3 |
| Dec 31, 2014 | 5 | - | - | 3 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| Aptevo Therapeutics | 37 |
| SeaStar Medical Holding | 19 |
| BioVie | 13 |
| BioRestorative Therapies | 11 |
| MetaVia | 9 |
| Immuron | 7 |
| Alzamend Neuro | 7 |
XTLB News
- 4 days ago - XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - GlobeNewsWire
- 15 days ago - XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership - GlobeNewsWire
- 4 weeks ago - XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 10 months ago - XTL Names Mr. Noam Band as its New Chief Executive Officer - GlobeNewsWire
- 1 year ago - XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million - GlobeNewsWire
- 1 year ago - XTL Entered Definitive Agreement to Acquire The Social Proxy - GlobeNewsWire
- 2 years ago - XTL To Aquire The Social Proxy - GlobeNewsWire
- 2 years ago - XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel - GlobeNewsWire